Sterling Capital Management’s Regulus Therapeutics RGLS Stock Holding History

Sterling Capital Management’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-830	Closed	-$1.45K	–	3374
2025 Q1	$1.45K	Sell	830 -788	-49%	-$1.04K	﹤0.01%	2692
2024 Q4	$2.56K	Buy	1,618 +1,452	+875%	+$2.23K	﹤0.01%	2712
2024 Q3	$261	Buy	+166	New	+$275	﹤0.01%	3068

Other funds holding RGLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sterling Capital Management's RGLS Position: Q2 2025 in Review

Sterling Capital Management sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 830 shares — an estimated $1.45K sold.

Sterling Capital Management first reported a position in RGLS in Q3 2024 and held it in 3 quarters. The position peaked at $2.56K in Q4 2024. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

Sterling Capital Management reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
Sterling Capital Management sold 830 Regulus Therapeutics shares in Q2 2025, an estimated $1.45K.
Sterling Capital Management first reported a position in Regulus Therapeutics in Q3 2024 and held it in 3 quarters.
Sterling Capital Management's Regulus Therapeutics position peaked at $2.56K in Q4 2024.
0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on Sterling Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.